HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhifeng Qi Selected Research

p38 Mitogen-Activated Protein Kinases

12/2007Cell type-specific activation of p38 MAPK in the brain regions of hypoxic preconditioned mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhifeng Qi Research Topics

Disease

19Ischemic Stroke
05/2024 - 01/2013
17Brain Ischemia (Cerebral Ischemia)
02/2024 - 04/2014
15Ischemia
02/2024 - 12/2007
9Stroke (Strokes)
01/2024 - 04/2014
7Hyperoxia
05/2024 - 01/2013
7Brain Injuries (Brain Injury)
02/2024 - 01/2013
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2023 - 04/2014
4Inflammation (Inflammations)
02/2024 - 01/2019
4Edema (Dropsy)
09/2023 - 05/2015
3Hypoxia (Hypoxemia)
10/2022 - 12/2007
3Hemorrhage
01/2021 - 01/2019
3Cerebral Infarction
12/2020 - 04/2014
3Infarction (Infarctions)
03/2015 - 04/2014
2Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2023 - 10/2018
2Reperfusion Injury
01/2023 - 01/2015
1Neuroinflammatory Diseases
02/2024
1Pathologic Processes
10/2023
1Brain Diseases (Brain Disorder)
01/2019
1Cerebral Hemorrhage
10/2017
1Brain Edema (Cerebral Edema)
01/2015
1Hypothermia
04/2014
1Necrosis
01/2013

Drug/Important Bio-Agent (IBA)

10ZincIBA
02/2024 - 04/2014
6Oxygen (Dioxygen)IBA
05/2024 - 01/2013
6Biomarkers (Surrogate Marker)IBA
01/2024 - 10/2017
6OccludinIBA
01/2024 - 10/2017
4N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA
01/2023 - 04/2014
4Chelating AgentsIBA
01/2023 - 10/2015
3Neuroprotective AgentsIBA
05/2024 - 10/2022
3Proteins (Proteins, Gene)FDA Link
10/2022 - 03/2015
3Tissue Plasminogen Activator (Alteplase)FDA Link
10/2018 - 05/2015
2Tight Junction ProteinsIBA
10/2023 - 10/2017
2Matrix Metalloproteinases (MMPs)IBA
10/2023 - 01/2015
2Cytochromes c (Cytochrome c)IBA
10/2022 - 10/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2018
2Evans Blue (Blue, Evans)FDA Link
11/2016 - 05/2015
2ErythropoietinFDA Link
03/2015 - 01/2015
1zinc-binding protein (zinc binding protein)IBA
10/2023
1Nuclear Proteins (Protein, Nuclear)IBA
01/2023
1Coloring Agents (Dyes)IBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
01/2023
1Interleukin-10 (Interleukin 10)IBA
01/2023
1Phospholipid Hydroperoxide Glutathione PeroxidaseIBA
10/2022
1Oxidoreductases (Dehydrogenase)IBA
10/2022
1ferrostatin-1IBA
10/2022
1Connexin 43 (Connexin43)IBA
10/2022
1ConnexinsIBA
10/2022
1NADPH Oxidase 4IBA
10/2022
1Protein Kinase CIBA
07/2020
1Mitogen-Activated Protein KinasesIBA
07/2020
1NF-kappa B (NF-kB)IBA
07/2020
1Peptides (Polypeptides)IBA
07/2020
1Hormones (Hormone)IBA
07/2020
1SteroidsIBA
07/2020
1fibrin fragment D (D-dimer)IBA
01/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2018
1Claudin-5IBA
10/2017
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
11/2016
1IonsIBA
11/2016
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
06/2015
1Beclin-1IBA
06/2015
1Fluorescein (Funduscein)FDA LinkGeneric
03/2015
1salubrinalIBA
03/2015
1isothiocyanic acidIBA
03/2015
1hydroxysafflor yellow AIBA
08/2014
1Poly (ADP-Ribose) Polymerase-1IBA
04/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2014
1GasesIBA
04/2014
1p38 Mitogen-Activated Protein KinasesIBA
12/2007

Therapy/Procedure

10Therapeutics
05/2024 - 01/2013
3Thrombectomy
01/2021 - 10/2018
1Duration of Therapy
05/2024
1Sutures (Suture)
10/2022
1Stents
01/2020
1Subcutaneous Injections
03/2015
1Intra-Arterial Infusions
03/2015
1Intravenous Administration
08/2014
1Thrombolytic Therapy
04/2014
1Laser Therapy (Surgery, Laser)
04/2014
1Drug Therapy (Chemotherapy)
04/2014